KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cardinal Health (CAH) EBIT Margin (2016 - 2025)

Cardinal Health's EBIT Margin history spans 17 years, with the latest figure at 1.08% for Q4 2025.

  • For Q4 2025, EBIT Margin rose 8.0% year-over-year to 1.08%; the TTM value through Dec 2025 reached 1.04%, up 18.0%, while the annual FY2025 figure was 1.02%, 47.0% up from the prior year.
  • EBIT Margin for Q4 2025 was 1.08% at Cardinal Health, up from 1.04% in the prior quarter.
  • Across five years, EBIT Margin topped out at 1.33% in Q1 2025 and bottomed at 2.09% in Q4 2021.
  • The 5-year median for EBIT Margin is 0.7% (2025), against an average of 0.51%.
  • The largest YoY upside for EBIT Margin was 254bps in 2021 against a maximum downside of -320bps in 2021.
  • A 5-year view of EBIT Margin shows it stood at 2.09% in 2021, then soared by 89bps to 0.23% in 2022, then soared by 480bps to 0.88% in 2023, then rose by 13bps to 0.99% in 2024, then increased by 8bps to 1.08% in 2025.
  • Per Business Quant, the three most recent readings for CAH's EBIT Margin are 1.08% (Q4 2025), 1.04% (Q3 2025), and 0.71% (Q2 2025).